The cause and effect of gut microbiota in development of inflammatory disorders of the breast

Table 2 Sensitivity analysis between gut microbiota and IDB

Exposure	Method	Q	Q_pval	MR Egger intercept	MR Egger pval	MR PRESSO pval
Eubacterium rectale group	MR Egger	8.04	0.15	− 0.01	0.90	0.27
Eubacterium rectale group	IVW	8.07	0.23	− 0.01	0.90	0.27
Bifidobacterium	MR Egger	19.68	0.29	0.08	0.02	0.07
	IVW	27.05	0.08	0.08	0.02	0.07
Olsenella	MR Egger	3.84	0.80	− 0.01	0.93	0.87
	IVW	3.84	0.87	− 0.01	0.93	0.87
Peptococcus	MR Egger	5.96	0.88	0.01	0.88	0.94
	IVW	5.99	0.92	0.01	0.88	0.94
Prevotella7	MR Egger	18.61	0.03	0.02	0.87	0.06
	IVW	18.67	0.04	0.02	0.87	0.06
Ruminiclostridium-6	MR Egger	8.91	0.71	0.02	0.65	0.80
	IVW	9.13	0.76	0.02	0.65	0.80
RuminococcaceaeUCG003	MR Egger	9.42	0.31	− 0.06	0.29	0.31
	IVW	10.94	0.28	− 0.06	0.29	0.31

IDB inflammatory disorders of the breast, GM gut microbiota, IVW inverse-variance weighted, MR Mendelian randomization

ISSN: 2047-783X